baber/WOPTO huggingface dataset:
Patent MY-174260-A (MY)
Title: Method and apparatus for packet transmission supporting downloading and streaming
Inventor: YOUNG-KWON LIM
IPC: H04L47/43
Filed: 2014-07-25
Abstract: A method and apparatus generate and process transport packets. A method of generating a transport packet by a sending entity (101) includes generating a transport packet to include a packet header, a payload header and a payload, the packet header comprising an identifier of a payload type in a field indicating one of a plurality of payload types, the plurality of payload types comprising a first payload type of a download mode and a second payload type of a streaming mode, and sending the transport packet.
Patent MY-180561-A (MY)
Title: An interconnection and insulation module for busbars
Inventor: HAMILTON ANTHONY JAMES
Filed: 2015-07-05
Abstract: An interconnection and insulation module is provided that is arranged to locate about a plurality of busbar pairs. Each busbar pair includes first and second busbars with an inter-busbar gap in between. The module includes opposed sides which accommodate the busbar pairs between them. Corresponding windows are formed through the opposed sides of the module and busbar separators extend from interior surfaces of the opposed sides. The bus bar separators locate interbusbar gaps for each busbar pair between one or more of the corresponding windows. Passages are defined between the corresponding windows of the opposed sides via the inter-busbar gaps for insertion of an electrical interconnection member. In use busbars can be readily interconnected by aligning their respective modules against each other and applying electrical interconnection members through the windows.  Figure 5
Patent MY-190574-A (MY)
Title: Straddled vehicle mounting an engine unit
Inventor: TATSUHIRO OBA
IPC: F02N11/04
Filed: 2017-09-26
Abstract: An engine unit (EU) includes a four-stroke single-cylinder engine body (10), a permanent magnet type rotary electric machine (20), an inverter (61) including switching parts (611 to 616), and a control device (CT). The control device (CT) configured to: perform a stop control of controlling the plurality of switching parts (611 to 616) such that a braking force is applied to forward rotation of a crankshaft (15) in at least part of a time period during which the crankshaft (15) continues forward rotation after stop of a combustion operation and until the crankshaft stops the forward rotation; and change the braking force at least once during the stop control, by changing an operation timing of the plurality of switching parts (611 to 616) based on both a position of the crankshaft (15) and an instantaneous value of the rotation speed of the crankshaft at the position.  (FIG. 1)
Patent MY-166237-A (MY)
Title: Engine controller and engine control method
Inventor: IMAOKA YOSHIHIRO
IPC: F02P5/15
Filed: 2015-04-16
Abstract: An engine controller (100) controls a direct fuel-injection, spark ignition engine (1) including a fuel injection valve (9) configured to directly inject a fuel into a cylinder (2), and an ignition plug that spark-ignites a mixture in the cylinder. The engine controller is provided with an acceleration request sensor configured to detect an acceleration request of a driver, and when the acceleration request occurs and a top surface temperature of a piston in the cylinder is lower than a predetermined temperature, the engine controller retards an ignition timing so that a period of time until a flame after the ignition reaches the piston top surface (3A) is extended. Figure 2
Patent MY-178018-A (MY)
Title: Route guidance method and route guidance device
Inventor: OKUYAMA TAKESHI
Filed: 2016-11-30
Abstract: A route guidance method includes: if, on a set route from a departure point to a destination of a vehicle, a travelling road at a present position of the vehicle has a first plurality of lanes, and a next road following a nearest branch point from the present position has a second plurality of lanes, finding a branch-merge point (J4) up to which lanes other than a lane for reaching the destination out of the second plurality of lanes have gone away; and if a start point (Ts) of traffic congestion is downstream of the branch-merge point, and an end point (Te) of the traffic congestion is upstream of the nearest branch point, guiding the vehicle to the lane for reaching the destination as a target before reaching the end point.  Figure 3
Patent MY-197875-A (MY)
Title: Cap-dependent endonuclease inhibitors
Inventor: HSU MING-CHU
IPC: C07D471/04
Filed: 2019-01-22
Abstract: Provided is a compound of Formula (I) below, or a pharmaceutically acceptable salt, metabolite, or prodrug thereof:  (I), wherein: A? is CR? or N; A? is CR??R?? or NR??; A? is CR??R?? or NR??; each of R?, R?, R?', R?, R??, R?, R?, R??, R?, R??, R?, and R??, independently, is hydrogen, deuterium, halogen, cyano, hydroxyl, carboxyl, amino, formyl, nitro, C?-? alkyl, C?-? alkenyl, C?-? alkynyl, C??? alkoxy, C??? alkenyloxy, C??? alkylcarbonyl, C??? alkyloxycarbonyl, C??? alkylamino, C???? carbocyclyl, or C???? heterocyclyl; or R? and R?, R?? and R??, or R? and R??, together with the adjacent atom to which they are each attached, form C???? carbocyclyl or C???? heterocyclyl. Further provided are a method of using the above-described compound, or the pharmaceutically acceptable salt, metabolite, or prodrug thereof for treating influenza and a pharmaceutical composition containing same.
Patent MY-197218-A (MY)
Title: Multispecific antigen-binding molecules and uses thereof
Inventor: ANDREEV JULIAN
IPC: C07K16/22
Filed: 2016-07-06
Abstract: The present invention provides multispecific antigen-binding molecules and uses thereof. The multispecific antigen-binding molecules comprise a first antigen-binding domain that specifically binds a target molecule, and a second antigen-binding domain that specifically binds an internalizing effector protein. The multispecific antigen-binding molecules of the present invention can, in some embodiments, be bispecific antibodies that are capable of binding both a target molecule and an internalizing effector protein. In certain embodiments of the invention, the simultaneous binding of the target molecule and the internalizing effector protein by the multispecific antigen-binding molecule of the present invention results in the attenuation of the activity of the target molecule to a greater extent than the binding of the target molecule alone. In other embodiments of the invention, the target molecule is a tumor associated antigen, and the simultaneous binding of the tumor associated antigen and the internalizing effector protein by the multispecific antigen-bindingmmolecule of the present invention causes or facilitates the targeted killing of tumor cells.
Patent MY-196751-A (MY)
Title: Method for manufacturing glass substrate for information recording medium
Inventor: Hazuki NAKAE
IPC: G11B5/84
Filed: 2013-09-06
Abstract: There is disclosed a disk-shaped glass substrate to be used for manufacturing a glass substrate (1) for an information recording medium (10), a main surface (2, 3) of the disk-shaped glass substrate having an arithmetic average roughness Raz, when a wavelength region is set to 2.5 ?m to 80 ?m, within a range of 0.1 ?m to 1.0 ?m.
Patent MY-174391-A (MY)
Title: Steering wheel structure
Inventor: CHEN-CHIH HUANG
Filed: 2014-06-16
Abstract: A steering wheel structure comprises a wheel base 10, an airbag module 20, two first compression springs 30, a second compression spring 40, two first resilience fasteners 50 and a second resilience fastener 60. The wheel base 10 has two first fixing portions 12 and a second hook 17 disposed in a triangle. Each first fixing portion 12 has a first through hole 15 penetrating to a bottom surface, one side of the second hook 17 has a through hole 18, a bottom surface of the airbag module 20 has two first hooks 21 and a second fixing portion 22, the second fixing portion 22 is formed with a second through hole 25 corresponding to the through hole 18, the two first compression springs 30 are fit with the two first hooks 21, respectively, and each first compression spring 30 has one end connected to the bottom surface of the airbag module 20, and the other end resting against the first fixing portion 12. The second compression spring 40 is disposed on a lateral side of the second fixing portion 22 and has one end connected to the bottom surface of the airbag module 20, and the other end resting against the wheel base 10. The two first resilience fasteners 50 are disposed on the two first fixing portions 12, respectively, and for resiliently fastening or releasing the two first hooks 21. The second resilience fastener 60 is disposed on the second fixing portion 22 and for resiliently fastening or releasing the second hook 17. The above-mentioned structure makes the assembling and disassembling between the airbag module 20 and the wheel base 10 easier, quicker and convenient, and makes the airbag module 20 and the wheel base 10, after being assembled, have the better tightness.
Patent SG-10201408414R-A (SG)
Title: Animal model expressing luciferase under control of the myelin basic protein promoter (mbp-luci) and use of the model for bioluminescence in vivo imaging
Inventor: CAO JAMES
Filed: 2010-12-03
Abstract: ANIMAL MODEL EXPRESSING LUCIFERASE UNDER CONTROL OF THE MYELIN BASIC PROTEIN PROMOTER (MBP-LUCI) AND USE OF THE MODEL FOR BIOLUMINESCENCE IN VIVO IMAGING A Myelin Basic Protein-luciferase bioimaging noninvasive model to visualize and quantify demyelination and remyelination events in the CNS at transcriptional level in vivo is provided. Luciferase-expressing transgenic animals were generated with myelin basic protein (MBP) promoter coupled to firefly luciferase reporter. The MBP- luci bioimaging model provides a means to monitor myelination status and the efficacy of a remyelination modulating test compound. An advantage of bioimaging is that a subject in a longitudinal study can serve as its own control. The same subject can be tracked over a demyelination and remyelination process continuously over a period of at least 10 weeks. This model enables normalization of individual animal imaging response and provides quality data with considerably reduced variance. In addition, because cohorts of animals need not be sacrificed at different time points, reduction in the number necessary for a compound efficacy study is possible. [Fig. 1]
Patent SG-10201609384R-A (SG)
Title: System and method for improving channel estimation of an ofdm-mimo channel
Inventor: YU QIAN
Filed: 2016-11-09
Abstract: SYSTEM AND METHOD FOR IMPROVING CHANNEL ESTIMATION OF AN OFDM-MIMO CHANNEL This document discloses a system and method for obtaining an improved channel estimation of an Orthogonal Frequency-Division Multiplexing (OFDM) Multiple-In and Multiple-Out (MIMO) channel. In particular, the disclosed system and method progressively computes channel estimations for each data symbol of a received packet and these updated channel estimations are then utilized to progressively improve the equalization of the packet’s data symbols. FIGURE 3
Patent SG-10201808035Y-A (SG)
Title: Moveable edge coupling ring for edge process control during semiconductor wafer processing
Inventor: HAOQUAN YAN
Filed: 2016-01-15
Abstract: MOVEABLEEDGE COUPLING RING FOR EDGE PROCESS CONTROL DURING SEMICONDUCTOR WAFER PROCESSING OFTHE DISCLOSURE A substrate processing system includes a processing chamber and a pedestal arranged in the processing chamber. An edge coupling ring is arranged adjacent to a radially outer edge of the pedestal. A first actuator is configured to selectively move the edge coupling ring to a raised position, relative to the pedestal to provide clearance between the edge coupling ring and the pedestal to allow a robot arm to remove the edge coupling ring from the processing chamber. FIG. 30
Patent SG-11201805536V-A (SG)
Title: Methods for characterizing compositions comprising peanut antigens
Inventor: ALVING KIM
IPC: G01N33/68
Filed: 2016-12-28
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -, Organization M1111101110101011111 HO 11111011101 0111101101110011101111111011 11 International Bureau ... ....Yejd (10) International Publication Number (43) International Publication Date ..... ..... WO 2017/115139 A2 6 July 2017 (06.07.2017) WI P0 I P CT (51) International Patent Classification: AO, G01N 33/68 (2006.01) BZ, DO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (21) International Application Number: HN, PCT/IB2016/001944 KP, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, (22) International Filing Date: MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, 28 December 2016 (28.12.2016) NI, RU, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, (25) Filing Language: English TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (26) Publication Language: English ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 62/272,094 29 December 2015 (29.12.2015) US kind 16306642.6 8 December 2016 (08.12.2016) EP GM, TZ, of regional protection available): ARIPO (BW, GH, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: SANOFI [FR/FR]; 54, Rue La Boetie, 75008 TJ, Paris (FR). DK, LV, (72) Inventors: ALVING, Kim; C/o Sanofi, 55 Corporate TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, Drive, Bridgewater, NJ 08807 (US). WANG, Bing, SM, Huang; C/o Sanofi, 55 Corporate Drive, Bridgewater, NJ GW, KM, ML, MR, NE, SN, TD, TG). TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, 08807 (US). DEMONTIGNY, Pierre; C/o Sanofi, 55 Published: Corporate Drive, Bridgewater, NJ 08807 (US). — without international search report and to be republished Designated States (unless otherwise indicated, for every upon receipt of that report (Rule 48.2(g)) (81) _ kind of national protection available): AE, AG, AL, AM, = = = = = = = = = = = = = ei C:7 M 11 kin ,-1 ,-1 IN ,-1 © ei (54) Title: METHODS FOR CHARACTERIZING COMPOSITIONS COMPRISING PEANUT ANTIGENS C :) ,..,.. (57) : Methods for determining an in vitro release profile of peanut allergens in a sample are provided. Methods for determ- ining one or more signatures of peanut allergens in a sample are provided.
Patent SG-11201811545Q-A (SG)
Title: System and method for hydroponic plant growth
Inventor: BATEMAN NICHOLAS
IPC: A01G31/06
Filed: 2017-06-30
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1 MEM 0 11101 HOE 100011101 1101 OH 100 1110 HIDE ill 0111111 Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/002647 Al 04 January 2018 (04.01.2018) W I PO I PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every AO1G 31/06 (2006.01) AO1G 31/04 (2006.01) kind of national protection available): AE, AG, AL, AM, (21) International Application Number: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, PCT/GB2017/051925 CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (22) International Filing Date: HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, 30 June 2017 (30.06.2017) KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (30) Priority Data: TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 1611428.2 30 June 2016 (30.06.2016) GB (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: H20-GANICS LIMITED [GB/GB]; 12 Mer- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, chants Quay, Pennygillam Industrial Estate, Launceston UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, Cornwall PL15 7QA (GB). TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (72) Inventors: BATEMAN, Nicholas; Quaker Root, Hother- EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, sall lane, Preston PR3 2XB (GB). BAYLEY, Joanne; MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, 11 Polvean Terrace, Duloe, Liskeard Cornwall PL14 4PF TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (GB). KM, ML, MR, NE, SN, TD, TG). (74) Agent: HANDSOME I.P. LTD; 27-28 Monmouth Street, Published: Bath Somerset BA1 2AP (GB). — with international search report (Art. 21(3)) = (54) Title: SYSTEM AND METHOD FOR HYDROPONIC PLANT GROWTH = 11 = = = = = = = = = Il IN 15 11' ei © 17 © ,-.... C (57) : The present invention provides a soilless plant el (11), with a plurality of carriages mounted on the conveyor „., of carriages, each tray (7) configured for growing at least --- t --- -\ and one \ -.) at plant growing ,- --- N least by \•-.) (Ths one means of hydroculture. system ',-.., tray 13 [Fig. 2] using a conveyor to move plants around a closed loop (7) configured to be received on each of the plurality
Patent SG-11201901759X-A (SG)
Title: Methods for treating ovarian cancer
Inventor: HATTERSLEY GARY
IPC: C07C217/84
Filed: 2017-09-27
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 1111111111111111111111111111111111111111111111111111111111111111111111111111111 Organization 0 International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/064231 Al 05 April 2018 (05.04.2018) WIP0 I PCT (51) International Patent Classification: A61K 31/137 (2006.01) CO 7C 217/84 (2006.01) (21) International Application Number: PCT/US2017/053834 (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/400,495 27 September 2016 (27.09.2016) US (71) Applicant: RADIUS HEALTH, INC. [US/US]; 950 Win- ter Street, Waltham, Massachusetts 02451 (US). (72) Inventor: HATTERSLEY, Gary; 14 Woodman Drive, Stow, Massachusetts 01775 (US). (74) Agent: WANG, Yingli; Perkins Coie LLP, P.O. Box 1247, Seattle, Washington 98111-1247 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, = =_ = = KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. = = = Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, = (84) = = UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, — TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, = _ _ EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, = MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, = TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, = KM, ML, MR, NE, SN, TD, TG). = — Declarations under Rule 4.17: = — — as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(0) as to the applicant's entitlement to claim the priority of the — — 1-1 earlier application (Rule 4.17(iii)) ..11 Published: 1 -1 — with international search report (Art. 21(3)) M ei ii- 0 --.... 00 1-1 (54) Title: METHODS FOR TREATING OVARIAN CANCER 0 N (57) : Methods of treating ovarian cancer are disclosed.
Patent SG-11201907927S-A (SG)
Title: Binding molecules that specifically bind to tau
Inventor: JURASZEK JAROSLAW
IPC: C07K16/18
Filed: 2018-03-27
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 04 October 2018 (04.10.2018) W I PO I PCT °mono n o Holm° Imo Imo VII IE (10) International Publication Number WO 2018/178077 Al (51) International Patent Classification: C07K 16/18 (2006.01) (21) International Application Number: PCT/EP2018/057770 (22) International Filing Date: 27 March 2018 (27.03.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 17163425.6 28 March 2017 (28.03.2017) EP (71) Applicant: JANSSEN VACCINES & PREVENTION B.V. [NL/NL]; Archimedesweg 4, 2333 CN Leiden (NL). (72) Inventors: JURASZEK, Jaroslaw; Archimedesweg 4-6, 2333 CN Leiden (NL). APETRI, Constantin, Adrian; Archimedesweg 4-6, 2333 CN Leiden (NL). (74) Agent: MANTEN, Annemieke et al.; Archimedesweg 4-6, 2333 CN Leiden (NL). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) of inventorship (Rule 4.17(iv)) Published: with international search report (Art. 21(3)) O 00 N 1-1 1-1 0 (57) : The invention relates to binding molecules and antigen-binding fragments that specifically bind to microtubule-asso- \" ciated protein tau. The invention also relates to diagnostic, prophylactic and therapeutic methods using the binding molecules or anti- 0 gen-binding fragments. (54) Title: BINDING MOLECULES THAT SPECIFICALLY BIND TO TAU
Patent SG-11201908428V-A (SG)
Title: Session filtering method and device
Inventor: WANG CHAOPI
IPC: H04L12/58
Filed: 2018-03-02
Abstract: SESSION FILTER ING METHOD AND DEVICE A session filtering method and a session filtering device are provided. The method may include: displaying session page entries corresponding to at least a part of communication sessions in which a user at the local end participates via a preset communication application, presentation areas of the session page entries containing filterable labels associated with the corresponding communication sessions; when any filterable label is triggered, filtering a communication session associated with the filterable label from the communication sessions corresponding to the displayed session page entries; and presenting the session page entries corresponding to the filtered communication sessions to user at local . Through the technical solution of this application, a communication session is quickly filtered and found, which is conducive to improve communication efficiency. Figure 2